ID   KS6A5_HUMAN             Reviewed;         802 AA.
AC   O75582; O95316; Q96AF7;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   05-OCT-2010, entry version 108.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-5;
DE            Short=S6K-alpha-5;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 5;
DE   AltName: Full=Nuclear mitogen- and stress-activated protein kinase 1;
DE   AltName: Full=RSK-like protein kinase;
DE            Short=RSKL;
GN   Name=RPS6KA5; Synonyms=MSK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-195 AND ASP-565.
RC   TISSUE=Pancreas;
RX   MEDLINE=98353467; PubMed=9687510; DOI=10.1093/emboj/17.15.4426;
RA   Deak M., Clifton A.D., Lucocq J.M., Alessi D.R.;
RT   "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly
RT   activated by MAPK and SAPK2/p38, and may mediate activation of CREB.";
RL   EMBO J. 17:4426-4441(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   MEDLINE=99091646; PubMed=9873047; DOI=10.1074/jbc.274.2.1026;
RA   New L., Zhao M., Li Y., Bassett W.W., Feng Y., Ludwig S., Padova F.D.,
RA   Gram H., Han J.;
RT   "Cloning and characterization of RLPK, a novel RSK-related protein
RT   kinase.";
RL   J. Biol. Chem. 274:1026-1032(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL LOCATION.
RX   MEDLINE=20169204; PubMed=10702687;
RA   Jiang C., Yu L., Tu Q., Zhao Y., Zhang H., Zhao S.;
RT   "Assignment of a member of the ribosomal protein S6 kinase family,
RT   RPS6KA5, to human chromosome 14q31-q32.1 by radiation hybrid
RT   mapping.";
RL   Cytogenet. Cell Genet. 87:261-262(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-549.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=11909979; DOI=10.1128/MCB.22.8.2871-2881.2002;
RA   Wiggin G.R., Soloaga A., Foster J.M., Murray-Tait V., Cohen P.,
RA   Arthur J.S.;
RT   "MSK1 and MSK2 are required for the mitogen- and stress-induced
RT   phosphorylation of CREB and ATF1 in fibroblasts.";
RL   Mol. Cell. Biol. 22:2871-2881(2002).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH RELA.
RX   MEDLINE=22515794; PubMed=12628924; DOI=10.1093/emboj/cdg139;
RA   Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W.,
RA   Haegeman G.;
RT   "Transcriptional activation of the NF-kappaB p65 subunit by mitogen-
RT   and stress-activated protein kinase-1 (MSK1).";
RL   EMBO J. 22:1313-1324(2003).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3 AND HMG14.
RX   PubMed=12773393; DOI=10.1093/emboj/cdg273;
RA   Soloaga A., Thomson S., Wiggin G.R., Rampersaud N., Dyson M.H.,
RA   Hazzalin C.A., Mahadevan L.C., Arthur J.S.;
RT   "MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation
RT   of histone H3 and HMG-14.";
RL   EMBO J. 22:2788-2797(2003).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H2A.
RX   PubMed=15010469; DOI=10.1074/jbc.M400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [9]
RP   ENZYME REGULATION, PHOSPHORYLATION AT SER-212; SER-376; SER-381;
RP   SER-750; SER-752 AND SER-758, AND MUTAGENESIS OF SER-212; SER-360;
RP   SER-376 AND THR-581.
RX   PubMed=15568999; DOI=10.1042/BJ20041501;
RA   McCoy C.E., Campbell D.G., Deak M., Bloomberg G.B., Arthur J.S.C.;
RT   "MSK1 activity is controlled by multiple phosphorylation sites.";
RL   Biochem. J. 387:507-517(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-554; LEU-574 AND CYS-599.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase required for the mitogen or
CC       stress-induced phosphorylation of the transcription factors CREB
CC       (cAMP response element-binding protein) and ATF1 (activating
CC       transcription factor-1). Essential role in the control of RELA
CC       transcriptional activity in response to TNF. Directly represses
CC       transcription via phosphorylation of 'Ser-1' of histone H2A.
CC       Phosphorylates 'Ser-10' of histone H3 in response to mitogenics,
CC       stress stimuli and epidemal growth-factor (EGF), which results in
CC       the transcriptional activation of several immediate early genes,
CC       including proto-oncogenes c-fos/FOS and c-jun/JUN. May also
CC       phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and
CC       stress-induced phosphorylation of high mobility group protein 14
CC       (HMG-14).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Appears to be activated by multiple
CC       phosphorylations on threonine and serine residues. ERK1/2 and
CC       MAPK14/p38-alpha may play a role in this process.
CC   -!- SUBUNIT: Forms a complex with either ERK1 or ERK2 in quiescent
CC       cells which transiently dissociates following mitogenic
CC       stimulation. Also associates with MAPK14/p38-alpha. Activated
CC       RPS6KA5 associates with and phosphorylates the NF-kappa-B p65
CC       subunit RELA.
CC   -!- INTERACTION:
CC       Q04206:RELA; NbExp=1; IntAct=EBI-73869, EBI-73886;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Predominantly
CC       nuclear. Partially cytoplasmic.
CC   -!- TISSUE SPECIFICITY: Widely expressed with high levels in heart,
CC       brain and placenta. Less abundant in lung, kidney and liver.
CC   -!- PTM: Ser-376 and Thr-581 phosphorylation is required for kinase
CC       activity. Ser-376 and Ser-212 are autophosphorylated by the C-
CC       terminal kinase domain, and their phosphorylation is essential for
CC       the catalytic activity of the N-terminal kinase domain.
CC   -!- MISCELLANEOUS: Enzyme activity requires the presence of both
CC       kinase domains.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 2 protein kinase domains.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF074393; AAC31171.1; -; mRNA.
DR   EMBL; AF080000; AAD23915.1; -; mRNA.
DR   EMBL; AF090421; AAC69577.1; -; mRNA.
DR   EMBL; BC017187; AAH17187.1; -; mRNA.
DR   IPI; IPI00335101; -.
DR   PIR; T13149; T13149.
DR   RefSeq; NP_004746.2; -.
DR   RefSeq; NP_872198.1; -.
DR   UniGene; Hs.510225; -.
DR   PDB; 1VZO; X-ray; 1.80 A; A=2-348.
DR   PDB; 3KN5; X-ray; 2.40 A; A/B=414-738.
DR   PDB; 3KN6; X-ray; 2.00 A; A/B=414-738.
DR   PDBsum; 1VZO; -.
DR   PDBsum; 3KN5; -.
DR   PDBsum; 3KN6; -.
DR   ProteinModelPortal; O75582; -.
DR   SMR; O75582; 46-383, 429-700.
DR   IntAct; O75582; 1.
DR   MINT; MINT-261060; -.
DR   STRING; O75582; -.
DR   PhosphoSite; O75582; -.
DR   PRIDE; O75582; -.
DR   Ensembl; ENST00000261991; ENSP00000261991; ENSG00000100784.
DR   GeneID; 9252; -.
DR   KEGG; hsa:9252; -.
DR   UCSC; uc001xys.1; human.
DR   CTD; 9252; -.
DR   GeneCards; GC14M091337; -.
DR   H-InvDB; HIX0020495; -.
DR   HGNC; HGNC:10434; RPS6KA5.
DR   HPA; CAB025458; -.
DR   HPA; HPA001274; -.
DR   MIM; 603607; gene.
DR   PharmGKB; PA34849; -.
DR   eggNOG; prNOG10707; -.
DR   HOGENOM; HBG315633; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; O75582; -.
DR   OMA; DSGHDKA; -.
DR   OrthoDB; EOG9VHNRR; -.
DR   PhylomeDB; O75582; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; lpa4_pathway; LPA4-mediated signaling events.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 34679; -.
DR   ArrayExpress; O75582; -.
DR   Bgee; O75582; -.
DR   CleanEx; HS_RPS6KA5; -.
DR   Genevestigator; O75582; -.
DR   GermOnline; ENSG00000100784; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling ...; TAS:UniProtKB.
DR   GO; GO:0016572; P:histone phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IDA:UniProtKB.
DR   GO; GO:0042221; P:response to chemical stimulus; IEP:UniProtKB.
DR   GO; GO:0009605; P:response to external stimulus; IEP:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IEP:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    802       Ribosomal protein S6 kinase alpha-5.
FT                                /FTId=PRO_0000086207.
FT   DOMAIN       49    318       Protein kinase 1.
FT   DOMAIN      319    387       AGC-kinase C-terminal.
FT   DOMAIN      426    687       Protein kinase 2.
FT   NP_BIND      55     63       ATP (By similarity).
FT   NP_BIND     432    440       ATP (By similarity).
FT   ACT_SITE    177    177       Proton acceptor (By similarity).
FT   ACT_SITE    544    544       Proton acceptor (By similarity).
FT   BINDING      81     81       ATP (By similarity).
FT   BINDING     455    455       ATP (By similarity).
FT   MOD_RES     212    212       Phosphoserine; by autocatalysis.
FT   MOD_RES     360    360       Phosphoserine; by MAPK3, MAPK1 and
FT                                MAPK14.
FT   MOD_RES     376    376       Phosphoserine; by autocatalysis.
FT   MOD_RES     381    381       Phosphoserine; by autocatalysis.
FT   MOD_RES     581    581       Phosphothreonine; by MAPK1, MAPK3 and
FT                                MAPK14.
FT   MOD_RES     750    750       Phosphoserine; by autocatalysis.
FT   MOD_RES     752    752       Phosphoserine; by autocatalysis.
FT   MOD_RES     758    758       Phosphoserine; by autocatalysis.
FT   VARIANT     190    190       H -> R (in dbSNP:rs34699345).
FT                                /FTId=VAR_051634.
FT   VARIANT     554    554       D -> N (in dbSNP:rs55911249).
FT                                /FTId=VAR_040634.
FT   VARIANT     574    574       P -> L (in dbSNP:rs34604933).
FT                                /FTId=VAR_040635.
FT   VARIANT     599    599       Y -> C (in dbSNP:rs55968863).
FT                                /FTId=VAR_040636.
FT   MUTAGEN     195    195       D->A: Loss of kinase activity.
FT   MUTAGEN     212    212       S->A: Inactives the N-terminal kinase
FT                                domain.
FT   MUTAGEN     360    360       S->A: Decreases kinase activity by 60% in
FT                                response to PMA and UV-C.
FT   MUTAGEN     376    376       S->A: Loss of kinase activity, and
FT                                decreases the phosphorylation of S-360
FT                                and T-581.
FT   MUTAGEN     565    565       D->A: Loss of kinase activity.
FT   MUTAGEN     581    581       T->A: Loss of kinase activity, and blocks
FT                                phosphorylation of S-212; S-376 and S-381
FT                                in response to PMA and UV-C.
FT   CONFLICT    452    453       FA -> LQ (in Ref. 3; AAC69577).
FT   CONFLICT    508    511       ERIK -> DALR (in Ref. 3; AAC69577).
FT   CONFLICT    532    532       V -> L (in Ref. 3; AAC69577).
FT   CONFLICT    538    538       V -> L (in Ref. 3; AAC69577).
FT   CONFLICT    549    549       N -> V (in Ref. 4; AAH17187).
FT   CONFLICT    588    590       YAA -> SCR (in Ref. 3; AAC69577).
FT   CONFLICT    757    758       SS -> RG (in Ref. 3; AAC69577).
FT   CONFLICT    801    802       VA -> ELRHGRSDQ (in Ref. 3; AAC69577).
FT   STRAND       26     31
FT   HELIX        46     48
FT   STRAND       49     57
FT   TURN         58     60
FT   STRAND       61     68
FT   TURN         72     75
FT   STRAND       77     94
FT   HELIX        95     97
FT   HELIX       101    109
FT   STRAND      117    123
FT   STRAND      126    131
FT   HELIX       139    146
FT   HELIX       151    170
FT   HELIX       180    182
FT   STRAND      183    185
FT   STRAND      191    194
FT   STRAND      196    201
FT   HELIX       204    210
FT   HELIX       212    214
FT   HELIX       222    225
FT   HELIX       235    250
FT   HELIX       264    273
FT   HELIX       284    293
FT   HELIX       298    300
FT   TURN        306    308
FT   HELIX       309    313
FT   HELIX       316    318
FT   HELIX       323    327
SQ   SEQUENCE   802 AA;  89865 MW;  76C27D0F6639BFA4 CRC64;
     MEEEGGSSGG AAGTSADGGD GGEQLLTVKH ELRTANLTGH AEKVGIENFE LLKVLGTGAY
     GKVFLVRKIS GHDTGKLYAM KVLKKATIVQ KAKTTEHTRT ERQVLEHIRQ SPFLVTLHYA
     FQTETKLHLI LDYINGGELF THLSQRERFT EHEVQIYVGE IVLALEHLHK LGIIYRDIKL
     ENILLDSNGH VVLTDFGLSK EFVADETERA YSFCGTIEYM APDIVRGGDS GHDKAVDWWS
     LGVLMYELLT GASPFTVDGE KNSQAEISRR ILKSEPPYPQ EMSALAKDLI QRLLMKDPKK
     RLGCGPRDAD EIKEHLFFQK INWDDLAAKK VPAPFKPVIR DELDVSNFAE EFTEMDPTYS
     PAALPQSSEK LFQGYSFVAP SILFKRNAAV IDPLQFHMGV ERPGVTNVAR SAMMKDSPFY
     QHYDLDLKDK PLGEGSFSIC RKCVHKKSNQ AFAVKIISKR MEANTQKEIT ALKLCEGHPN
     IVKLHEVFHD QLHTFLVMEL LNGGELFERI KKKKHFSETE ASYIMRKLVS AVSHMHDVGV
     VHRDLKPENL LFTDENDNLE IKIIDFGFAR LKPPDNQPLK TPCFTLHYAA PELLNQNGYD
     ESCDLWSLGV ILYTMLSGQV PFQSHDRSLT CTSAVEIMKK IKKGDFSFEG EAWKNVSQEA
     KDLIQGLLTV DPNKRLKMSG LRYNEWLQDG SQLSSNPLMT PDILGSSGAA VHTCVKATFH
     AFNKYKREGF CLQNVDKAPL AKRRKMKKTS TSTETRSSSS ESSHSSSSHS HGKTTPTKTL
     QPSNPADSNN PETLFQFSDS VA
//
